share_log

InterCure Ltd. (NASDAQ:INCR) Sees Significant Decline in Short Interest

InterCure Ltd. (NASDAQ:INCR) Sees Significant Decline in Short Interest

InterCure有限公司(納斯達克代碼:INCR)認為空頭股數的銷量大幅下降
Defense World ·  2022/08/17 04:51

InterCure Ltd. (NASDAQ:INCR – Get Rating) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 79,600 shares, a drop of 6.9% from the July 15th total of 85,500 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 55,400 shares, the days-to-cover ratio is currently 1.4 days.

InterCure Ltd.(納斯達克評級:INCR-GET)看到空頭股數在7月份出現了顯著下降。截至7月31日,空頭股數共有79,600股,較7月15日的85,500股下降了6.9%。該公司約0.3%的股票被賣空。以日均成交量55,400股計算,目前天數與回補比率為1.4天。

InterCure Stock Down 3.2 %

InterCure股價下跌3.2%

INCR stock opened at $6.02 on Wednesday. The firm has a market cap of $257.26 million and a PE ratio of 50.17. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.26 and a current ratio of 1.67. The firm's fifty day moving average is $6.00 and its 200 day moving average is $6.37. InterCure has a one year low of $5.42 and a one year high of $8.77.

週三,INCR的股票開盤報6.02美元。該公司市值為2.5726億美元,市盈率為50.17倍。該公司的負債權益比率為0.07,速動比率為1.26,流動比率為1.67。該公司的50日移動均線切入位為6.00美元,200日移動均線切入位為6.37美元。InterCure的一年低點為5.42美元,一年高位為8.77美元。

Get
到達
InterCure
InterCure
alerts:
警報:

InterCure (NASDAQ:INCR – Get Rating) last released its quarterly earnings results on Monday, May 16th. The company reported $0.11 EPS for the quarter. The company had revenue of $27.29 million for the quarter. InterCure had a net margin of 5.38% and a return on equity of 3.23%.

InterCure(納斯達克:INCR-GET評級)最近一次發佈季度收益報告是在5月16日(星期一)。該公司公佈本季度每股收益為0.11美元。該公司本季度的收入為2729萬美元。InterCure的淨利潤率為5.38%,股本回報率為3.23%。

Institutional Trading of InterCure

InterCure的機構交易

Institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC lifted its stake in shares of InterCure by 70.4% in the second quarter. Citadel Advisors LLC now owns 25,661 shares of the company's stock worth $149,000 after buying an additional 10,598 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of InterCure by 756.0% in the second quarter. JPMorgan Chase & Co. now owns 6,309 shares of the company's stock worth $37,000 after buying an additional 5,572 shares in the last quarter. Citigroup Inc. lifted its stake in shares of InterCure by 9,567.9% in the first quarter. Citigroup Inc. now owns 5,124 shares of the company's stock worth $36,000 after buying an additional 5,071 shares in the last quarter. Davy Global Fund Management Ltd purchased a new position in shares of InterCure in the first quarter worth about $152,000. Finally, ETF Managers Group LLC purchased a new position in InterCure during the fourth quarter worth about $3,592,000. Institutional investors and hedge funds own 9.34% of the company's stock.
機構投資者最近調整了對該股的持有量。Citadel Advisors LLC在第二季度增持了70.4%的InterCure股票。Citadel Advisors LLC現在持有該公司25,661股股票,價值149,000美元,上個季度又購買了10,598股。摩根大通在第二季度增持了756.0%的InterCure股票。摩根大通在上個季度又購買了5,572股,目前持有6,309股該公司股票,價值37,000美元。花旗集團(Citigroup Inc.)在第一季度增持了9,567.9%的InterCure股票。花旗集團(Citigroup Inc.)在上個季度增持了5,071股後,目前持有5,124股該公司股票,價值36,000美元。Davy Global Fund Management Ltd在第一季度購買了InterCure的新頭寸,價值約15.2萬美元。最後,ETF Manager Group LLC在第四季度購買了InterCure的一個新頭寸,價值約3,592,000美元。機構投資者和對衝基金持有該公司9.34%的股票。

About InterCure

關於InterCure

(Get Rating)

(獲取評級)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.

InterCure有限公司及其子公司在以色列和國際上從事醫用大麻產品的研究、種植、生產、營銷和分銷。它提供乾燥的大麻花序和混合了油的大麻提取物。該公司還投資於BioMed部門。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on InterCure (INCR)
  • Are These 3 Video Game Stocks Now In Play?
  • 2 Long-Term EV Plays Trading Under $20
  • Why Apple is Primed to Take a Bite Out of Live Sports
  • Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
  • Home Depot Results Point To Sluggish 2nd Half
  • 免費獲取StockNews.com關於InterCure的研究報告(INCR)
  • 這3只電子遊戲股票現在還在玩嗎?
  • 2輛長期電動汽車的交易價格低於20美元
  • 蘋果為何準備退出體育直播
  • 埃克森美孚和西方石油導致內幕人士本月大量買入
  • 家得寶業績指向低迷的下半年

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.

接受InterCure Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對InterCure和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論